Quanta Pharma Yohimbine 10mg x 100 tablets

£37.00

Description
Reviews (0)

Quanta Pharma Yohimbine 10mg x 100 Tablets

Quanta Pharma Yohimbine 10mg x 100 tablets deliver a potent alpha–2 adrenergic receptor antagonist designed for advanced fat loss protocols. This pharmaceutical-grade compound targets stubborn adipose tissue resistant to diet and exercise. Quanta Pharma ensures precise 10mg dosing in every tablet, providing researchers and athletes with reliable data for performance studies. The 100-tablet package supports extended cutting cycles or long-term metabolic research.

Key Features

Exact 10mg Yohimbine HCL per tablet for precise dosing
100-tablet bulk packaging for extended research cycles
Manufactured by Quanta Pharma under strict quality control
High–purity Yohimbine Hydrochloride formulation
Sealed blister packs maintain stability and potency
Ideal for stubborn fat loss research and metabolic studies
Fast–acting formula with rapid absorption rates
Compatible with advanced cutting and recomp protocols

Mechanism of Action

Yohimbine functions as a selective alpha–2 adrenergic receptor antagonist. The compound binds to alpha-2 receptors located on fat cells. This binding blocks the inhibitory signals that normally prevent fat breakdown. Blocking these receptors increases norepinephrine release in the body. Elevated norepinephrine levels stimulate lipolysis, the process of breaking down stored fat. The compound specifically targets alpha-2 rich areas like the lower abdomen, hips, and thighs. These areas typically resist standard fat loss methods due to high alpha-2 receptor density. Yohimbine reverses this resistance, allowing stubborn fat to be utilized as energy. The mechanism requires low insulin levels to function effectively.

Benefits

Mobilizes stubborn fat stores resistant to diet and exercise
Increases lipolysis and fat oxidation rates
Enhances norepinephrine activity for improved metabolic rate
Supports lean muscle preservation during calorie deficits
Improves body composition in advanced cutting phases
Provides measurable data for metabolic research studies
Increases energy expenditure through thermogenic effects
Targets specific problem areas with high alpha-2 receptor density

When to Use Yohimbine

During advanced cutting phases with low body fat levels
When stubborn fat pockets resist standard diet and training
For metabolic research on alpha-2 receptor antagonism
In combination with fasting protocols for maximum efficacy
During pre-contest preparation for competitive athletes
For studies on lipolysis and fat mobilization mechanisms
When insulin levels are naturally low (fasted state)
Under strict medical or research supervision only

Dosage Guidelines

Standard research dosage ranges from 0.2mg to 0.3mg per kilogram of body weight
Typical daily dose falls between 10mg and 20mg maximum
Administer in a fasted state for optimal results
Split dosage into two sessions if using higher amounts
Avoid carbohydrate intake within 4 hours of administration
Discontinue use immediately if adverse reactions occur
Do not exceed 30mg daily under any circumstances
Cycle usage: 2 weeks on, 2 weeks off to prevent receptor desensitization

Product Specifications

Active Ingredient: Yohimbine Hydrochloride
Strength: 10mg per tablet
Package Count: 100 tablets
Manufacturer: Quanta Pharma
Form: Oral tablets
Storage: Store in cool, dry place away from light
Shelf Life: As indicated on packaging
Legal Status: Research chemical / Prescription only in many jurisdictions

Conclusion

Quanta Pharma Yohimbine 10mg x 100 tablets represent a specialized tool for advanced metabolic research and stubborn fat loss protocols. By specifically targeting alpha-2 adrenergic receptors, this compound offers a unique mechanism to mobilize resistant adipose tissue that standard diet and exercise cannot address. The precise 10mg dosage allows researchers to conduct accurate studies on lipolysis and body composition modification. However, the efficacy of Yohimbine is strictly dependent on physiological conditions, particularly low insulin levels, making fasting protocols essential for any successful application. While the potential for enhancing fat loss is significant, the compound carries risks that demand respect and caution. It is not suitable for beginners, individuals with cardiovascular issues, or those unable to adhere to strict dosing and cycling guidelines. Quanta Pharma ensures that each tablet meets high pharmaceutical standards, providing the consistency required for serious scientific inquiry. When used correctly under professional supervision, this product serves as a powerful asset in the arsenal against stubborn fat, but it must be approached with a clear understanding of its potent pharmacological effects and safety requirements.